Marinoff, Amanda E.
Nathrath, Michaela
Shulman, David S.
Whittle, Sarah B.
Pavisic, Jovana
Spentzos, Dimitrios
Albert, Catherine M.
Nash, Joshua O.
Shlien, Adam
Cortés-Ciriano, Isidro
Marchais, Antonin
López-Fuentes, Eunice
Curtis, Christina
Sweet-Cordero, E. Alejandro
Gorlick, Richard
DelRocco, Natalie
Chugh, Rashmi
Tap, William D.
Flanagan, Adrienne M.
Gaspar, Nathalie
Crompton, Brian D.
Reed, Damon R.
Janeway, Katherine A.
Grohar, Patrick J.
Livingston, J. Andrew
Roberts, Ryan D.
Funding for this research was provided by:
National Cancer Institute (K12CA260225)
Rally Foundation (No specific grant number)
The Casper Colson philanthropic donation to the Sarcoma Program at the MGH Cancer Center and the Amy Chase McMahon Sarcoma Research Fund at the MGH Cancer Center (No specific grant number)
National Institute for Health Research, UCLH Biomedical Research Centre, the UCL Experimental Cancer Centre, and the UCL / UCLH Biobank for Studying Health and Disease (No specific grant number)
Article History
Received: 6 January 2026
Accepted: 20 April 2026
First Online: 5 May 2026
Competing interests
: A.S. is a co-founder of NewCode Oncology, which has licensed a cancer diagnostic platform from The Hospital for Sick Children (SickKids). All other authors declare no competing interests.